Armen Shanafelt's most recent trade in Aeglea BioTherapeutics Inc was a trade of 43,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on June 7, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics Inc | Armen Shanafelt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 43,000 | 43,000 | - | - | Director Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Armen Shanafelt | Director | Purchase of securities on an exchange or from another person at price $ 3.67 per share. | 09 Dec 2021 | 121,799 | 121,799 (0%) | 0% | 3.7 | 446,759 | Common Stock |
| Aeglea BioTherapeutics Inc | Armen Shanafelt | Director | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 09 Dec 2021 | 14,685 | 150,000 (0%) | 0% | 3.6 | 53,600 | Common Stock |
| Aeglea BioTherapeutics Inc | Armen Shanafelt | Director | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 09 Dec 2021 | 13,516 | 135,315 (0%) | 0% | 3.6 | 49,333 | Common Stock |
| Aeglea BioTherapeutics Inc | Armen Shanafelt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 40,000 | 40,000 | - | - | Director Stock Option (right to buy) |